Can a capsaicin patch ease diabetic foot pain? new study investigates

NCT ID NCT06495424

Ongoing Symptom relief Sponsor: Averitas Pharma, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study is testing whether repeated use of QUTENZA (a capsaicin 8% patch) can reduce pain and the need for painkillers in adults with painful diabetic nerve damage in the feet. About 144 participants will receive up to three patch applications, each 12 weeks apart. Researchers will track pain scores, quality of life, and medication use to see if the treatment works in real-world settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: capsaicin 8% patch (QUTENZA)
What this could lead to: If successful, this could provide real-world evidence that repeated QUTENZA treatments safely reduce diabetic nerve pain and the need for pain medications.
What could go wrong: This is an observational study, not a controlled trial, so results may be less reliable. It is also small (144 people) and only looks at short-term effects over three treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAINFUL DIABETIC NEUROPATHY PERIPHERAL DIABETIC NEUROPATHY

Contacts and locations

Locations

Center for Interventional Pain and Spine

Wilmington, Delaware, 19808, United States
Center for Interventional Pain and Spine

Bryn Mawr, Pennsylvania, 19010, United States
Center for Interventional Pain and Spine

Fort Washington, Pennsylvania, 19034, United States
Center for Interventional Pain and Spine

Lancaster, Pennsylvania, 17601, United States
Curalta Clinical Trials

Oradell, New Jersey, 07649, United States
Horizon Clinical Research

Gainesville, Georgia, 30501, United States
Horizon Clinical Research

Jasper, Georgia, 30143, United States
Horizon Clinical Research

Newnan, Georgia, 30265, United States
Iqra Research

Edgewood, Kentucky, 41017, United States
Iqra Research

Cincinnati, Ohio, 45248, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.